SWOG 1918: A phase II/III randomized study of R-miniCHOP with or without oral azacitidine (CC-486) in participants age 75 years or older with newly diagnosed aggressive non-Hodgkin lymphomas – Aiming to improve therapy, outcomes, and validate a prospective frailty tool
| Autor: | Brem, Elizabeth A., Li, Hongli, Beaven, Anne W., Caimi, Paolo F., Cerchietti, Leandro, Alizadeh, Ash A., Olin, Rebecca, Henry, N. Lynn, Dillon, Hildy, Little, Richard F., Laubach, Cara, LeBlanc, Michael, Friedberg, Jonathan W., Smith, Sonali M. |
|---|---|
| Zdroj: | In Journal of Geriatric Oncology March 2022 13(2):258-264 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect